Algorae Pharmaceuticals (ASX:1AI) Price-to-Tangible-Book : 5.75 (As of Jun. 08, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Algorae Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-06-08), Algorae Pharmaceuticals's share price is A$0.0115. Algorae Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.00. Hence, Algorae Pharmaceuticals's Price to Tangible Book Ratio of today is 5.75.

The historical rank and industry rank for Algorae Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Algorae Pharmaceuticals's highest Price to Tangible Book Ratio was 8.65. The lowest was 1.36. And the median was 3.73.

ASX:1AI's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Algorae Pharmaceuticals's share price is A$0.0115. Algorae Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.00. Hence, Algorae Pharmaceuticals's P/B Ratio of today is 5.75.

Algorae Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Algorae Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algorae Pharmaceuticals Price-to-Tangible-Book Chart

Algorae Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.24

2.27

5.66

2.63

7.50

Algorae Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.36	2.63	5.93	7.50	5.00

Competitive Comparison of Algorae Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Algorae Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algorae Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algorae Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Algorae Pharmaceuticals's Price-to-Tangible-Book falls into.

Algorae Pharmaceuticals Price-to-Tangible-Book Calculation

Algorae Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.0115	/	0.002
	=	5.75

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Algorae Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Algorae Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Algorae Pharmaceuticals (ASX:1AI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algorae Pharmaceuticals Ltd (ASX:1AI) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

LVCLY:USA LVCLF:USA LHI0:Germany

Address

201 Sussex Street, Level 16, Tower 2, Darling Park, Sydney, NSW, AUS, 2000

Website

https://www.algoraepharma.com

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

Algorae Pharmaceuticals (ASX:1AI) Headlines

No Headlines